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ABSTRACT consumption and an impaired capacity to metabolize glucose. These 
Fructose 2,6-bisphosphate concentration, 6-phosphofructo 2-kinase/ results stress the relevance of the PFK-P/fructose 2,6-bisphosphate 
fructose 2,6-bisphosphatase (PFK-2/FBPase2) activity, and messenger system in the control of the glycolytic flux in liver, and these changes 
RNA decreased in maternal rat liver during the last days of gestation, are intended to prevent glucose consumption by maternal liver and 
and the recovery started after delivery. Phospho(eno1)pyruvat.e car- contribute to allow gluconeogenesis to proceed at the end of gestation. 
boxykinase activity and messenger RNA increased in contrast to PFK- The physiological basis of this adaptation may lay on the diversion of 
2 changes. Measurement of the glycolytic capacity in isolated hepato- glucose from maternal to fetal metabolism. (Endocrinology 133: IO&- 
cytes prepared from rata 1 h after parturition showed a low glucose 1050,1993) 
D URING the late period of pregnancy important changes occur in liver carbohydrate metabolism manifested in 
a maternal hypoglycemia, despite the development of differ- 
ent mechanisms devoted to favor glucose production (i.e. 
hyperphagia) and to reduce its consumption (insulin resist- 
ance) (l-3). Although the precise hormonal contribution to 
this adaptive process is not clear, it has been proposed that 
in this period the high level of circulating catecholamines 
and PRL, and more precisely the drop in plasma insulin in 
the last 2 days of gestation, contribute to the increased 
gluconeogenic capacity of pregnant rats, especially during 
fasting states (4-6). 
One of the control points of the glycolytic/gluconeogenic 
fluxes is located at the 6-phosphofructo 1-kinase/fructose 
1,6-bisphosphatase level and is modulated by the changes 
in the concentration of fructose 2,6-bisphosphate (Fru-2,6- 
P2). In liver, this metabolite is synthesized and degraded by 
the bifunctional enzyme 6-phosphofructo 2-kinase (PFK-2)/ 
Fru-2,6-P,, which is under both rapid and long-term dietary 
and hormonal control (7, 8). Rapid regulation is mediated 
after activation of CAMP-dependent protein kinase, which 
through the phosphorylation in a unique Ser residue in the 
enzyme causes the inhibition of the kinase and the activation 
of the bisphosphatase activities, resulting in a decrease in 
Fru-2,6-P2 concentration (9). Long-term regulation is me- 
diated by the control of PFK-2 gene expression (lo), which 
is decreased in situations such as diabetes, hypothyroidism, 
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and prolonged starvation (8-l 1). 
In this report we show an important decrease in liver PFK- 
2 during the late period of pregnancy and discuss the possible 
physiological relevance of this adaptive response. 
Materials and Methods 
Chemicals 
[a-32P]deoxycytidine triphosphate, [cu-32P]uridine hiphosphate (3000 
Ci/mmol), and [U-“CJglucose (2 mCi/mmol) were from Amersham 
(Buckinghamshire, UK). Dowex AGlX8 was from Bio-Rad (Richmond, 
CA). Restriction enzymes were from Boehringer (Mannheim, Germany). 
Agarose was from Pharmacia (Uppsala, Sweden). Other chemicals and 
biochemicals were from Sigma (St. Louis, MO) or Merck (Dannstadt, 
Germany). 
Liver preparation 
Pregnant albino Wistar rats (300-350 g) fed ad libitum on a standard 
laboratory diet were used. Pregnancy and gestational age were deter- 
mined by standard criteria (12), and the animals were killed between 
0830-0930 h, except for time zero of parturition, in which only animals 
that delivered between 0800-1030 h were used. To collect the tissue, 
maternal rat livers were removed and quickly freeze-clamped in liquid 
N2. The clamps (30 cm*) were precooled in liquid nitrogen before use. 
The frozen tissue was crushed with a pestle and stored at -80 C. 
Isolation and incubation of hepatocytes 
Isolated hepatocytes were prepared by the classic collagenase perfu- 
sion method (13). Cell viability was determined by the trypan blue 
exclusion criteria and was higher than 90%. Hepatocytes (5-7 X lo6 
cells per flask) were incubated for 15 min at 37 C in 2 ml Krebs- 
bicarbonate buffer and continuous gassing with carbogen before use. 
After this incubation period cells were challenged with hormones or 
incubated with various concentrations of glucose (25 pCi/mmol). At the 
indicated times, aliquots of the cell suspension were collected to measure 
metabolites and enzyme activities. When the fate of glucose in hepato- 
cyte suspensions was investigated, the cells were preincubated for 5 min 
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in the presence of 5 mM glucose and for an additional 10 min in its 
absence before use. 
Preparation of liver homogenates 
Livers were homogenated l/4 (wt/vol) in an Ultra-Turrax homoge- 
nizer in a medium containing 20 mM potassium phosphate, 1 rnr.4 
dithiothreitol, 1 mM EDTA, 50 mu NaF, and 0.5 mM phenylmethane- 
sulfonyl fluoride (pH 7.4 at 4 C). After centrifugation at 100,000 X g for 
30 min the supematant was delipidated through glass-wool filtration 
and either filtered through Sephadex G-25 (medium) or fractionated 
with poly(ethyleneglyco1) 6000 (PEG), and the 2-15% PEG pellet was 
resuspended in 0.25 vol homogenization buffer. 
Metabolite and enzyme assays 
Fru-2,6-P2 was extracted from cells or liver after homogenization (l/ 
20, wt/vol) with 50 mM NaOH followed by heating at 80 C for 10 min. 
The metabolite was measured by the activation of the PI?-dependent 
phosphofructo I-kinase (14). Lactate was measured enzymically (13) in 
the hepatocyte suspension after neutralization of perchloric acid extracts 
(0.5 M final concentration). “C-Labeled anions were measured in the 
cell pellets after centrifugation at 80 X g for 2 min and deproteinization 
with 2 ml ice-cold 0.5 M perchloric acid. After neutralization (pH 8.0) 
and centrifugation for 10 min in a Eppendorf centrifuge, 1.5 ml of the 
supematants were applied to a Dowex AGlX8 (OH- form) column (2 x 
0.5 cm) equilibrated with 20 mu Tris, pH 8.0, 20 mM NaCI. After 
washing the column with equilibration buffer until no more radioactivity 
emerged, the radioactive anions were eluted in 2 ml 0.5 M NaCl, 50 mu 
HCI, and 1 ml was counted in 10 ml scintillation fluid. PFK-2 was 
assayed after partial purification with PEG (15). Kinetic changes induced 
after phosphorylation of the enzyme were assessed by measuring the 
maximum velocity at pH 8.5 and pH 6.6 as described by Martin-Sanz et 
al. (13) and Bartrons et al. (15). Both phosphorylated and dephosphor- 
ylated enzymes are active when assayed at pH 8.5 (total activity), 
whereas at pH 6.6 (active form), only the dephosphorylated enzyme 
retains its full catalytic activity. The total activity was measured at pH 
8.5 in the presence of 5 mM fructose 6-phosphate (Fru 6-phosphate), 5 
mu MgATP, and 1 mM potassium phosphate. The active form of PFK-2 
was assayed at pH 6.6 in the presence of 1 mM Fru 6-phosphate, 5 mM 
MgATP and 1 mu potassium phosphate. Fru 6-phosphate was in a 1:3 
ratio with glucose &phosphate (glc 6-phosphate). brie unit of PFK-2 
was defined as forming 1 pmol Fru-2,6-P&run at 30 C. Other enzyme 
activities were measured in homogenate supematants (100,000 X g for 
30 min) after sephadex G-25 filtration: glucokinase was assayed using 
10 mu JU-“Clglucose (1 uCi) in the uresence or absence of 1 mM elc 6- 
phosphate. Thi reaction was’stopped by spotting 25 ~1 reaction r&me 
to a P81 paper filter (Whatman, Clifton, NJ) and was processed as 
described by Van Schaftingen (16). Pyruvate kinase was assayed at pH 
7.4 in the presence of 2 mM MgADl’ and 2 mu phospho(enol)pyruvate 
(17). Phosphoenolpyruvate carboxykinase (PEPCK) was measured with 
5 mM pyruvate as described by Ballard and Hanson (18). Protein was 
measured by the method of Bradford (19) using BSA as standard. 
RNA analysis and DNA hybridization probes 
Total RNA was extracted by the guanidinium thiocyanate method 
(20). Aliquots of RNA (30 pg) were denatured at 65 C for 15 min in 5% 
formaldehyde, 50% formamide, and 8% glycerol, and then were size- 
separated by electrophoresis in a 0.9% agarose gel containing 2% form- 
aldehyde and 3-(N-morpholino)propanesulfonic acid buffering system 
(21). After transference of the RNA to Nytran membranes (NY i3-N; 
Schleicher & Schuell, Keene. NH) with 10X SSC (10X SSC is 1.5 M 
NaCl, 0.3 M sodium citrate, pH 7.4), the membranes were prehybridized 
for 6 hat 42 C in 50% formamide, 0.25 M NaCl, 0.1 M sodium phosphate, 
7% sodium dodecyl sulfate and 0.01% salmon sperm. The PFK-2/ 
FBPase-2 messenger RNA (mRNA) level was detected with a 1.4- 
kilobase (kb) EcoRI fragment isolated from the complementary DNA 
(cDNA) of PFK-2/FBPase-2 (8), labeled (37% efficiency) with [a-32P] 
deoxycytidine triphosphate using the random-primed labeling kit (Boeh- 
ringer). Northern blot analysis of PEPCK RNA was carried out using a 
2.4-kb PstI probe isolated from a pBR322 vector (kindly supplied by Dr. 
J. P. Garcia-Ruiz, Autonomous University, Madrid, Spain). The mem- 
branes were washed with 0.1X SSC and 0.1% sodium dodecyl sulfate 
at room temperature for 10 min and twice at 50 C for 30 min, followed 
by exposure to x-ray film (Kodak X-OMAT; Eastman Kodak Co., Roch- 
ester, NY). Quantification of the films was performed by laser densitom- 
etry (Molecular Dynamics, Sunnyvale, CA) using the hybridization with 
a B-actin probe (0.6-kb EcoRI/HindIII fragment isolated from the VC 18 
vector) as an internal standard. 
Data analysis 
All experiments were carried out by assaying the samples per dupli- 
cate or triplicate. Statistical analysis was performed by the Student’s f 
test for paired data (parametric test) and by the Wilcoxon test (nonpar- 
ametric values). The statistical significance of differences between preg- 
nant and virgin rats was evaluated by the U of Mann-Whitney test (22). 
The significance has been considered at P < 0.05. 
Results 
Maternal liver PFK-2 activity and Fru-2,6-Pz concentration 
are decreased around the time of delivery 
The profile of maternal liver PFK-2 and Fru-2,6-P2 re- 
vealed important changes during the last days of pregnancy. 
As Fig. 1A shows, a decrease in the maximal activity of PFK- 
2 (measured at pH 8.5) is observed. The lowest activity was 
detected around delivery and represented a 53% of decrease 
in the specific activity when compared to that of 3-month- 
old virgin rats (52 + 8 U/mg protein). The so-called active 
form of the enzyme (assayed at pH 6.6) was also measured 
in the same fractions and represents the activity of the 
dephosphorylated enzyme (15, 13). This activity, measured 
at pH 6.6, was also minimal (38% of the total activity) during 
delivery, implying an increase in PFK-2 phosphorylation by 
CAMP-dependent protein kinase during this period. The 
activity ratio at pH 8.5/pH 6.6 reflects the phosphorylation 
state of the enzyme and increases from 1.7 (day 19 of 
gestation) to 2.7 on the parturition day, returning to basal 
values at days l-2 after labor (Fig. 1B). Interesting enough is 
the profile of liver Fru-2,6-P2 content (Fig. 1B) that progres- 
sively decreases during the last 3 days of gestation (87% 
decrease at delivery when referred to 3-month-old virgin 
rats), evolving in parallel with the inactivation of PFK-2 by 
phosphorylation. The liver Fru-2,6-P, content at days 17 and 
18 of gestation was similar to that measured at day 19 (not 
shown). 
In addition to PFK-2, the activities of glucokinase, pyru- 
vate kinase, and PEPCK were also measured throughout this 
period as markers of relevant enzymes controlling the gly- 
colytic/gluconeogenic fluxes in liver (Fig. 2). All these activ- 
ities were assayed in parallel and were referred to those of 
3-month-old virgin rats. Whereas pyruvate kinase remained 
unchanged along this period, an increased activity of PEPCK 
(283%) and a decreased activity of glucokinase (50%) were 
observed before parturition. Indeed, the inactivation of PFK- 
2 activity and the probable fall in glc 6-phosphate concen- 
tration as the result of the decreased glucokinase activity 
may be related to the low concentration of Fru-2,6-P2 found 
in maternal liver during the last 2 days of pregnancy. 
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FIG. 1. PFK-2 activity and Fru-2,6-P* -g 
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FIG. 2. Enzyme activities profile in maternal liver. Livers (three or 
four animals) were homogenized, and the activities of pyruvate kinase 
(A), glucokinase (0), and PEPCK (A) were measured as described in 
Materids and Methods. Glucokinase was measured in the presence of 
1 mM glc B-phosphate. Besults were expressed as the percentage of the 
activity corresponding to 90-day-old virgin rats fed ad libitum, and the 
enzyme activities in these animals were 1.5,150, and 31 mU/mg protein 
for glucokinase, pyruvate kinase, and PEPCK, respectively. Results 
are the means f  SEM of at least three different animals. **, P C 0.01, 
maternal us. 90-day-old virgin rats. 
PFK-2/Fru-2,6-P2 mRNA paralkkr PFK-2 activity 
To determine whether the abundance of PFK-2/FBPase-2 
mRNA correlates with the enzyme activity, RNA from ma- 
ternal liver was prepared for Northern blot analysis using a 
1.4-kb cDNA probe. As shown in Fig. 3A, the PFK-2/FBPase- 
2 mRNA content during the last 3 days of pregnancy de- 
creased to 10% of the content in control animals (90-day-old 
virgin rats). The recovery of mRNA levels started 1 day after 
delivery, exhibiting a good parallelism with the PFK-2 activ- 
ity and Fru-2,6-P* concentration profiles (Figs. 1 and 3B). In 
contrast to the fall in PFK-2 mRNA, an increase in PEPCK 
lactation pregnancy lactation 
mRNA was observed around delivery, exhibiting a peak 
value at parturition @-fold increase over the value of 3- 
month-old virgin rats). Again, there is a good correlation 
between the increase in PEPCK activity and in mRNA con- 
tent along this period. In addition, Northern blot analysis of 
PEPCK was done in the same membranes used for PFK-2/ 
FBPase-2 analysis and therefore constituted an internal con- 
trol for the evolution of both mRNA in these animals. 
Maternal liver contains the adult hepatic form of PFK-2 
The maternal liver profile of PEPCK and PFK-2 observed 
around parturition strongly resembles the expression pattern 
of these enzymes in regenerating liver (23, 24), and in this 
situation the presence of a PFK-2 isoenzyme distinct to that 
prevailing in adult liver is suggested. One characteristic of 
this form, shared in common with the enzyme expressed in 
fetal liver (25, 26), is the loss of inhibition of PFK-2 after 
phosphorylation by CAMP-dependent protein kinase. To test 
this possibility, maternal hepatocytes were prepared from 
animals 1 h after parturition, and the effect of glucagon on 
both the enzyme activity and the Fru-2,6-P2 content was 
assayed. As shown in Fig. 4A, the ratio of the activities of 
PFK-2 assayed at pH 8.5 and pH 6.6 increased after exposure 
of the cells to glucagon. The activity assayed at pH 6.6 
decreased, whereas the activity at pH 8.5 remained un- 
changed, suggesting a phosphorylation-dependent inactiva- 
tion of the enzyme (7, 27). Parallel to this inhibition, an 
important and rapid decrease in the concentration of Fru- 
2,6-P2 was observed after incubation of the cells with 100 
nM glucagon (Fig. 4B). This important decrease in Fru-2,6-P2 
is an additional proof reinforcing the presence of the adult 
hepatic form of PFK-2 in maternal liver. Ancillary informa- 
tion obtained from this experiment is the great relevance of 
the hormonal situation during pregnancy on the control of 
Fru-2,6-P2 levels; the Fru-2,6-P* content in animals around 
parturition is almost negligible (14 pmol/mg protein); how- 
ever, after isolation and incubation of the hepatocytes in the 
absence of the maternal hormonal ambience, an important 
deinhibition of PFK-2 occurs, resulting in an increase in Fru- 
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FIG. 3. Northern blot analysis of PFK-2 and PEPCK mRNA. Total 
RNA (30 fig per lane) was extracted from maternal rat livers (three or 
four animals) and processed by Northern blot. A, Representative ex- 
periment (of three) using a cDNA for PFK-2 or PEPCK. Both blots 
were performed in the same membrane. B, Densitometric scanning of 
autoradiograms corresponding to PFK-2 (0) and PEPCK (0) were 
corrected for the amount of RNA corresponding to @-actin mRNA and 
were matched for normalization with the values of PFK-2 and PEPCK 
RNA of virgin rata 90 days old, which were considered 100%. 
2,6-P2 concentration (43 pmol/mg protein) and in a decrease 
in the ratio of PFK-2 activity assayed at pH 8.5 and pH 6.6 
(Figs. 1 and 4). 
Glucose sparing in maternal liver 
To evaluate the physiological role of the changes in the 
enzyme activities relevant for the control of the glycolytic/ 
gluconeogenic fluxes, the fate of glucose was investigated in 
hepatocyte suspensions obtained from animals 1 h after 
parturition. As Fig. 5 shows, maternal hepatocytes challenged 
with increasing concentrations of glucose exhibited a very 
low glycolytic flux (measured as lactate release) when com- 
pared with hepatocytes obtained from 90-day-old virgin rats. 
At physiological glucose concentrations (5-6 mu), the rate of 
lactate production by maternal hepatocytes was only 30% of 
that of control cells. Moreover, the analysis of the content of 
charged molecules after incubation with [U-14C]glucose re- 
vealed an important fall in charged species that roughly 
corresponds to a concomitant decrease in glucose consump- 
tion (see lactate release under these conditions). This behav- 
ior was observed even at glucose concentrations higher than 
5 mM, a situation in which important glycolysis occurs (28). 
Parallel results were observed when the.concentration of 
Fru-2,6-P* was measured in these conditions. Taken together, 
these results stress the physiological relevance of the decrease 
in Fru-2,6-P2 concentration and in the total PFK-2 activity in 
the control of the glycolytic flux in maternal liver. Moreover, 
the decrease in PFK-2 activity is reinforced by the phosphor- 
ylation-induced inactivation of the enzyme in this physiolog- 
ical situation. 
Discussion 
The studies on the physiological adaptations elicited dur- 
ing the late period of pregnancy in mammals have stressed 
the relevance of the rapid and specific hormonal changes 
and the occurrence of an unusual substrate metabolism in 
this situation (29). A major advance in the understanding of 
the fetal role in maternal homeostasis was the recognition of 
the central role played by glucose in the maternal/fetal 
substrate exchange, higher than for any of the substrates so 
far analyzed (30). This is the result of the high selectivity of 
the placental barrier for the exchange of hormones and 
substrates, allowing a clear cut-off between maternal and 
fetal circulations. As a consequence of the high glucose 
requirements for fetal development, a series of changes in 
the maternal metabolism have been accomplished and are 
intended to preserve glucose consumption and to favor the 
use of other alternative fuels, among them triglyceride con- 
sumption by liver, enhanced lipolysis, and an increase in the 
circulating ketone bodies (29, 30). An important issue that 
summarizes the maternal situation during pregnancy is the 
concept launched by Freinkel(31) of ‘accelerated starvation,” 
as depicting the adaptive metabolic changes occurring at the 
end of pregnancy. The high flux of glucose from the maternal 
to fetal circulation is due to the high structural and energetic 
requirements of the fetus for growth, to the absence of an 
efficient amino acid transport system, and to the placental 
impermeability to glycerolipids and fatty acid traffic (29-32). 
Indeed, this central role played by glucose for fetal metabo- 
lism is reinforced by the fact that fetal liver lacks the ability 
to produce glucose from any of the substrates that may cross 
the placental barrier (33, 34). 
In agreement with this preservation of glucose for fetal 
metabolism, and therefore, a decrease in maternal glycolytic 
flux, our results clearly show a transient drop in Fru-2,6-PZ 
concentration and in mRNA and enzyme activity of PFK-2 
in the last 3-4 days of gestation, evolving in parallel. A rapid 
recovery started immediately after delivery. The fall in Fru- 
2,6-PZ during the last day of gestation is impressive. More- 
over, due to the low specific activity of fructose 1,6-bisphos- 
phatase and its relatively high affinity for Fru-2,6-P2, it may 
be expected a very low free concentration of this metabolite 
(less than 14 pmol/mg protein) (28), and therefore, the 
glycolytic flux through 6-phosphofructo I-kinase would be 
minimal (27, 28). 
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FIG. 4. Effect of glucagon on PFK-2 ac- 
tivity and on Fru-2,6-P* concentration 
in isolated maternal hepatocytes. Hepa- 
tocytes were prepared from rats 1 h after 
parturition and were incubated in the 
absence (0) or presence of 100 nM glu- 
cagon (0). The activity of PFK-2 was 
assayed at pH 8.5 and 6.6 and expressed 
as activity ratio (A). The corresponding 
Fru-2,6-P, concentration was measured 
(B). Results are the means f  SEM of 
three independent hepatocyte prepara- 
tions. *, P C 0.001 glucagon us. none. 
0 5 10 15 
glucose, (mbll 
25 
FIG. 5. Glycolytic flux in isolated hepatocytes from maternal rats. 
Hepatocytes were isolated from rats 1 h after delivery (closed symbols) 
or from control virgin rats aged 3 months (open symbols). The hepa- 
tocyte suspension was allowed to incubate for 15 min in the absence of 
glucose, and cells were challenged with the indicated concentrations of 
[U-“Clglucose (25 pCi/mmol). Samples were collected after 15 min of 
incubation for the measurement of Fru-2,6-Pz, and after 30 min of 
incubation for the determination of the anion content after Dowex 
AGlX8 (OH- form) chromatography. Samples intended for the meas- 
urement of lactate production (1.5 ml cell suspension) were collected 
after 30 min of incubation and were deproteinized with perchloric acid. 
Lactate was measured enzymically. Results are means of two inde- 
pendent cell preparations. 
To understand the role of the changes in the PFK-2/ 
FBPase-2 system in the pregnant rat, it is of interest to 
compare this adaptive response with those physiological and 
pathological situations in which an important decrease in the 
activity of PFK-2 occurs; prolonged fasting, diabetes, or 
partial hepatectomy (8, 23, 35, 36) produce an important 
drop in Fru-2,6-P* concentration, PFK-2 activity, and in some 
cases, a decrease in the mRNA content. Concerning the levels 
of PFK-2/FBPase-2 mRNA detected in maternal liver, it is 
noteworthy that a similar pattern is observed after partial 
liver hepatectomy (23), with a transient (hours) decrease in 
mRNA concentration and an important drop in Fru-2,6-P* 
10 20 
time, (mid 
30 0 10 20 30 
time, (mid 
concentration (24). However, a major difference exists be- 
tween regenerating and maternal liver before labor: whereas 
maternal PFK-2 activity retains its capacity to be inhibited 
after treatment of the hepatocytes with glucagon, this effect 
is apparently lost in regenerating liver after hepatectomy (23, 
24). 
The hormonal contribution to this fall in the maternal 
hepatic PFK-2/FBPase-2 system and in the increase in 
PEPCK activity and mRNA remains to be established, but 
three important components for this behavior may be envi- 
sioned: 1) The hepatic insulin resistance described at the end 
of gestation, probably due to an impaired tyrosine kinase 
activity of the receptor (29,30, 37). In fact, the plasma levels 
of insulin increase 3-fold at day 20 of gestation (38), reaching 
the value of 3-month-old virgin rats the last day of preg- 
nancy. The development of a hepatic insulin resistance may 
help both the maintenance of the phosphorylated state of 
PFK-2 via its stimulatory effects on the serine/threonine 
protein phosphatase activity (39) and a decrease in the PFK- 
2/FBPase-2 mRNA levels through a mechanism similar to 
that described in diabetic animals by other authors, although 
this aspect of PFK-2 regulation is controversial (35, 36). 2) 
Hormones increasing CAMP levels such as glucagon may 
promote a situation similar to that observed during fasting 
(8, 23). In agreement with this suggestion, treatment of 
hepatocytes with glucagon produced a rapid decrease in 
mRNA of PFK-2/FBPase-2 (our unpublished results). In the 
context of the hormonal situation at the end of the preg- 
nancy, more relevant than glucagon is probably PRL. The 
levels of PRL are increased during the last days of pregnancy 
and maintained along lactation. Although in liver a PRL- 
dependent CAMP increase is well documented, the complex- 
ity of the PRL membrane receptor system suggests the exist- 
ence of a highly regulated action for this hormone (40, 41). 
3) Catecholamines are also increased, and they may contrib- 
ute to the augmented gluconeogenic activity in the late period 
of pregnancy (30). It is noteworthy that the changes in 
PEPCK activity occur at the transcriptional level, in contrast 
with the situation of PFK-2/FBPase-2 (42). Little is known 
about the proteins involved in the stabilization of mRNA, 
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although the so-called poly(A)-binding proteins have been 
proposed as protectors against degradation (43). In addition 
to this, many mRNAs are stabilized in the presence of protein 
synthesis inhibitors (as is the case for the fetal hepatic form 
of PFK-2), suggesting the involvement of short-lived proteins 
in the mRNA degradation system. In conclusion, it is possible 
that the specific profile of PFK-2/FBPase-2 changes may be 
the result of different hormonal and metabolic contributions 
that converge in a common mechanism intended to promote 
a decreased glycolytic capacity in liver at the end of gestation. 
Concerning PEPCK, our results show a shift between the 
PEPCK mRNA levels and enzyme activity during the last 
days of pregnancy that may be attributed to several factors. 
One of the relevant signals in the control of PEPCK expres- 
sion is CAMP that also stabilizes the mRNA against degra- 
dation (44). Moreover, in these in viva experiments in which 
multiple hormones affect the expression of PEPCK at differ- 
ent levels, it is difficult to determine the exact contribution 
of different hormones to the mRNA and enzyme activity 
profiles observed during the last days of gestation. However, 
this is not the case with PFK-2, in which an acceptable 
parallelism between enzyme activity and mRNA levels is 
observed around delivery. 
A further point of interest is the observation that maternal 
and neonatal changes concerning the expression of glyco- 
lytic/gluconeogenic enzymes are quite different. After birth, 
the neonatal hypoglycemia after glycogen depletion triggers 
the expression of PEPCK (6) and promotes the switch of 
PFK-2 from the fetal form to the liver-type isoenzyme fol- 
lowing a time course similar to that of PEPCK (25, 26), the 
process being completed in viva approximately 12 h after 
birth. In contrast to this situation, maternal PEPCK and PFK- 
2 exhibit opposite behavior along the perinatal period. Ma- 
ternal PFK-2/FBPase-2 mRNA decreases by the effect of 
glucagon, whereas fetal PFK-2 mRNA is increased by this 
hormone (our unpublished results). 
The observation that at delivery the total amount of PFK- 
2 and mRNA are decreased by about 55 and 90%, respec- 
tively, and that the enzyme is inactivated by phosphorylation 
(activity at pH 6.6), producing an 85% decrease in Fru-2,6- 
PZ concentration, reinforces the relevance of this system in 
the metabolic control to of the glycolytic flux in this period, 
and in so doing diverts the glucose fate from maternal to 
fetal metabolism. Accordingly, maternal hepatocytes exhib- 
ited a very low glycolytic capacity when compared with the 
virgin counterparts. Taken together, these results stress the 
relevance of a drastic drop in the concentration of Fru-2,6- 
PZ in the inhibition of glucose consumption, and through 
this mechanism this metabolite facilitates the process of 
gluconeogenesis. 
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